RecruitingNCT04318366
COVID-19 Patients Characterization, Biobank, Treatment Response and Outcome Predictor
Study to Characterize Patients With SARS-Cov-2 Infection and to Create a Biobank to Identify Predictors of Disease Severity, Mortality and Treatment Response
Sponsor
Università Vita-Salute San Raffaele
Enrollment
6,000 participants
Start Date
Mar 19, 2020
Study Type
OBSERVATIONAL
Conditions
Summary
Collection and analysis of demographic, clinical, radiographic and laboratory characteristics of CoViD-19 patients to identify predictors of disease severity, mortality and treatment response, and to identify subgroup of patients that might benefit from specific therapeutic interventions
Eligibility
Min Age: 18 Years
Inclusion Criteria3
- Patients admitted to hospital with biological samples positive for SARS-CoV-2
- Patients admitted to hospital with negative test but clinical and radiological characteristics highly suggestive of SARS-CoV-2 disease
- Patients discharged from emergency department with biological samples positive for SARS-CoV-2
Exclusion Criteria1
- None
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
OTHERObservational Study
Not required
Locations(13)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT04318366